Tesamorelin Dosage Guide

Complete guide to Tesamorelin dosing protocols, administration methods, and safety considerations for research purposes.

Research Use Only: The dosage information provided is for educational and research purposes. Peptides are not approved by the FDA for human use. Always consult with a healthcare professional.

Recommended Dosage

FDA-approved dose: 2mg administered subcutaneously once daily. Research protocols may use various dosing schedules.

Administration Method

Subcutaneous injection into the abdomen. Rotate injection sites. Best administered at the same time daily, preferably in the evening.

Side Effects to Monitor

Common side effects include injection site reactions (erythema, pruritus), joint pain, peripheral edema, and muscle pain. May cause elevated blood glucose.

Safety Considerations & Risks

Contraindicated in patients with active malignancy, hypersensitivity to GHRH, or during pregnancy. May affect glucose metabolism. Requires monitoring of IGF-1 levels.